Tudor Investment Corp
MNTA

Tudor Investment Corp’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Tudor Investment Corp’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,000
Closed -$197K – 1456
2019
Q4 		$197K Buy
+10,000
New +$160K 0.01% 996
2017
Q2 		– Sell
-19,100
Closed -$255K – 1500
2017
Q1 		$255K Sell
19,100
-4,029
-17% -$63.1K 0.01% 1098
2016
Q4 		$348K Buy
23,129
+3,398
+17% +$44.9K 0.01% 937
2016
Q3 		$231K Buy
+19,731
New +$232K 0.01% 1180
2015
Q4 		– Sell
-19,347
Closed -$317K – 1919
2015
Q3 		$317K Buy
19,347
+3,415
+21% +$69.9K 0.01% 1067
2015
Q2 		$363K Buy
+15,932
New +$317K 0.01% 990
2014
Q2 		– Sell
-29,800
Closed -$347K – 1395
2014
Q1 		$347K Buy
+29,800
New +$505K 0.01% 727
2013
Q4 		– Sell
-10,600
Closed -$153K – 1394
2013
Q3 		$153K Buy
+10,600
New +$162K 0.01% 759

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Tudor Investment Corp's MNTA Position: Q1 2020 in Review

Tudor Investment Corp sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2020, closing a stake of 10,000 shares — an estimated $197K sold.

Tudor Investment Corp first reported a position in MNTA in Q3 2013 and held it in 8 quarters. The position peaked at $363K in Q2 2015. 199 funds tracked by Wall St. Rank hold MNTA as of Q1 2020.

  • Tudor Investment Corp reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Tudor Investment Corp sold 10,000 Momenta Pharmaceuticals, Inc. shares in Q1 2020, an estimated $197K.
  • Tudor Investment Corp first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 8 quarters.
  • Tudor Investment Corp's Momenta Pharmaceuticals, Inc. position peaked at $363K in Q2 2015.
  • 199 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2020.

Based on Tudor Investment Corp's 13F filing for Q1 2020, filed 15 May 2020.